• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液学疾病与心脏

Hematological diseases and the heart.

作者信息

Can Ferda

机构信息

Division of Hematology, Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara, Turkiye.

出版信息

Turk J Med Sci. 2024 Dec 2;54(7):1438-1446. doi: 10.55730/1300-0144.5929. eCollection 2024.

DOI:10.55730/1300-0144.5929
PMID:39735486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11673626/
Abstract

The heart, as the main part of the circulatory system, is one of the organs frequently affected by hematological diseases. Cardiac problems may develop during the course and treatment of benign and malignant hematological diseases. This review study was conducted based on recent information from the literature and manifestations of cardiac involvement in hematology were summarized. Determining appropriate cardiac approaches in cases of hematological diseases with relevant knowledge and experience regarding the development of cardiac involvement in pathophysiological conditions has an important role in the diagnosis and treatment processes of patients. This review provides relevant information about hematological diseases and the heart, and key points that will help in the diagnosis and treatment process are presented.

摘要

心脏作为循环系统的主要组成部分,是血液系统疾病常累及的器官之一。在良性和恶性血液系统疾病的病程及治疗过程中可能会出现心脏问题。本综述研究基于文献中的最新信息进行,总结了血液学中心脏受累的表现。凭借有关病理生理状况下心脏受累发展的相关知识和经验,确定血液系统疾病患者合适的心脏治疗方法在患者的诊断和治疗过程中具有重要作用。本综述提供了有关血液系统疾病与心脏的相关信息,并呈现了有助于诊断和治疗过程的关键点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a2/11673626/f13b1421afe3/tjmed-54-07-1438f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a2/11673626/f13b1421afe3/tjmed-54-07-1438f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a2/11673626/f13b1421afe3/tjmed-54-07-1438f1.jpg

相似文献

1
Hematological diseases and the heart.血液学疾病与心脏
Turk J Med Sci. 2024 Dec 2;54(7):1438-1446. doi: 10.55730/1300-0144.5929. eCollection 2024.
2
Imaging of Spinal Manifestations of Hematological Disorders.血液系统疾病脊柱表现的影像学检查
Hematol Oncol Clin North Am. 2016 Aug;30(4):921-44. doi: 10.1016/j.hoc.2016.03.011. Epub 2016 Jun 7.
3
[Cardiac and hematological involvement in idiopathic hypereosinophilic syndrome. Study of 12 cases].[特发性高嗜酸性粒细胞综合征的心脏和血液学受累情况。12例病例研究]
Med Clin (Barc). 1992 Feb 8;98(5):161-5.
4
[Research Progress on the Role of Musashi-2 in the Pathogenesis of Malignant Hematologic Diseases-Review].[Musashi-2在恶性血液系统疾病发病机制中的作用研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):633-636. doi: 10.7534/j.issn.1009-2137.2017.02.060.
5
Laparoscopic Splenectomy for Benign Hematological Disorders in Adults: A Systematic Review.成人良性血液系统疾病的腹腔镜脾切除术:一项系统评价
In Vivo. 2017 May-Jun;31(3):291-302. doi: 10.21873/invivo.11058.
6
Pulmonary complications in patients with hematological disorders: pathobiological bases and practical approach.血液系统疾病患者的肺部并发症:病理生物学基础与实际处理方法
Semin Respir Crit Care Med. 2005 Oct;26(5):439-44. doi: 10.1055/s-2005-922028.
7
[Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Editorial: Immune-mediated hematological diseases].[免疫介导的血液系统疾病的诊断与治疗新进展。社论:免疫介导的血液系统疾病]
Nihon Naika Gakkai Zasshi. 2014 Jul 10;103(7):1561-3. doi: 10.2169/naika.103.1561.
8
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).血液系统疾病患者(包括异基因干细胞移植)的中枢神经系统感染——德国血液学和肿瘤内科学会(DGHO)传染病工作组(AGIHO)指南
Ann Oncol. 2016 Jul;27(7):1207-25. doi: 10.1093/annonc/mdw155. Epub 2016 Apr 6.
9
Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate.母胎单位疾病:胎儿及新生儿的血液学表现
Semin Perinatol. 2009 Feb;33(1):12-9. doi: 10.1053/j.semperi.2008.10.005.
10
Marching against blood diseases: a report from the 51st Annual Meeting of the American Society of Hematology (December 5-8, 2009 - New Orleans, Lousiana, USA).向血液疾病进军:美国血液学会第51届年会(2009年12月5 - 8日 - 美国路易斯安那州新奥尔良)报告
Drugs Today (Barc). 2010 Mar;46(3):195-230. doi: 10.1358/dot.2010.46.3.1490753.

本文引用的文献

1
Development of a pharmaceutical database as an aid to the nonclinical detection of drug-induced cardiac toxicity.开发一个药物数据库,以帮助非临床检测药物引起的心脏毒性。
J Pharmacol Toxicol Methods. 2024 May-Jun;127:107507. doi: 10.1016/j.vascn.2024.107507. Epub 2024 Apr 16.
2
Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis.新型单克隆抗体:轻链淀粉样变性的真正特异性治疗方法。
Hematol Oncol. 2024 May;42(3):e3270. doi: 10.1002/hon.3270.
3
A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines.
化疗药物所致心律失常及中药潜在干预的综述
Front Pharmacol. 2024 Mar 20;15:1340855. doi: 10.3389/fphar.2024.1340855. eCollection 2024.
4
[Cardiotoxicity risk assessment of anti-cancer drugs and future perspectives].[抗癌药物的心脏毒性风险评估及未来展望]
Nihon Yakurigaku Zasshi. 2024;159(2):83-89. doi: 10.1254/fpj.23094.
5
Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis.免疫球蛋白轻链型心脏淀粉样变诊断与治疗中国专家共识
Chin Med J (Engl). 2024 Jan 20;137(2):127-129. doi: 10.1097/CM9.0000000000002961. Epub 2023 Dec 22.
6
Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis, and Treatment.心脏淀粉样变性:临床特征、发病机制、诊断和治疗。
Turk Patoloji Derg. 2024;40(1):1-9. doi: 10.5146/tjpath.2023.12923.
7
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.免疫球蛋白轻链淀粉样变性:2024年诊断、预后及治疗的最新进展
Am J Hematol. 2024 Feb;99(2):309-324. doi: 10.1002/ajh.27177. Epub 2023 Dec 14.
8
Acute myocardial infarction in myeloproliferative neoplasms.骨髓增殖性肿瘤中的急性心肌梗死
World J Cardiol. 2023 Nov 26;15(11):571-581. doi: 10.4330/wjc.v15.i11.571.
9
Cardiovascular Risk in Patients with Hematological Malignancies: A Systematic Review and Meta-Analysis.血液系统恶性肿瘤患者的心血管风险:系统评价和荟萃分析。
Am J Cardiol. 2024 Feb 1;212:80-102. doi: 10.1016/j.amjcard.2023.11.039. Epub 2023 Dec 1.
10
Drug-induced cardiac toxicity and adverse drug reactions, a narrative review.药物性心脏毒性和药物不良反应:叙述性综述
Therapie. 2024 Mar-Apr;79(2):161-172. doi: 10.1016/j.therap.2023.10.008. Epub 2023 Oct 31.